Back To Schedule
Monday, June 20 • 2:40pm - 3:10pm
#126 IT: Medable Innovation Theater: The Real R&D Accelerator

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Component Type: Session

Innovation in medicine no longer resides in research labs.Indeed the key to solving R&D stagnation is deploying technology that can slash clinical trial timelines & accelerate needed therapies to market.Recent evidence shows that DCT solutions save 1-3 mths for a typical phase 2/3 trial generating a net benefit of up to 14x the initial investment.These savings could cover substantial portions of top pharma companies’ total yearly R&D spend & open possibilities of bringing more drugs to patients.




Pamela Tenaerts, MD, MBA

Kenneth Getz, MBA

avatar for Medable


United States
avatar for Pamela Tenaerts

Pamela Tenaerts

Chief Scientific Officer, Medable, United States
As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement responsible decentralized trial strategies for sponsors, sites and patients. Dr. Tenaerts brings more than 30 years of experience in clinical... Read More →
avatar for Kenneth Getz

Kenneth Getz

Executive Director/Professor, Tufts CSDD; Founder/Board Chair, CISCRP, Tufts University School of Medicine, United States
Ken Getz is a Professor and the Executive Director of the Center for the Study of Drug Development, Tufts University School of Medicine, where he conducts grant-funded studies on pharmaceutical R&D management and execution; protocol design optimization; CRO and investigative site... Read More →

Monday June 20, 2022 2:40pm - 3:10pm CDT
Exhibit Hall Theater #2 McCormick Place 2301 South Indiana Avenue Gate 40 Chicago, IL 60616